These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35879875)

  • 1. Verification of the fCAL turbo immunoturbidimetric assay for measurement of the fecal calprotectin concentration in dogs and cats.
    Enderle LL; Köller G; Heilmann RM
    J Vet Diagn Invest; 2022 Sep; 34(5):813-824. PubMed ID: 35879875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preanalytical validation of an in-house radioimmunoassay for measuring calprotectin in feline specimens.
    Heilmann RM; Grützner N; Handl S; Suchodolski JS; Steiner JM
    Vet Clin Pathol; 2018 Mar; 47(1):100-107. PubMed ID: 29377247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical validation of an enzyme-linked immunosorbent assay for the quantification of S100A12 in the serum and feces of cats.
    Bridges CS; Grützner N; Suchodolski JS; Steiner JM; Heilmann RM
    Vet Clin Pathol; 2019 Dec; 48(4):754-761. PubMed ID: 31820477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.
    Garnett E; Pagaduan J; Rajapakshe D; Tam E; Kellermayer R; Devaraj S
    Pract Lab Med; 2020 Nov; 22():e00178. PubMed ID: 33134465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers.
    Nilsen T; Sunde K; Hansson LO; Havelka AM; Larsson A
    J Clin Lab Anal; 2017 Jul; 31(4):. PubMed ID: 27629827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and analytic validation of an immunoassay for the quantification of canine S100A12 in serum and fecal samples and its biological variability in serum from healthy dogs.
    Heilmann RM; Lanerie DJ; Ruaux CG; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):200-9. PubMed ID: 22030158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.
    Mandic-Havelka A; Nilsen T; Sunde K; Norell M; Hansson LO; Larsson A
    Clin Lab; 2017 May; 63(5):907-913. PubMed ID: 28627817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.
    Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C
    Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and analytic validation of a radioimmunoassay for the quantification of canine calprotectin in serum and feces from dogs.
    Heilmann RM; Suchodolski JS; Steiner JM
    Am J Vet Res; 2008 Jul; 69(7):845-53. PubMed ID: 18593232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay.
    Åsberg A; Løfblad L; Felic A; Hov GG
    Scand J Clin Lab Invest; 2019; 79(1-2):50-57. PubMed ID: 30761918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis.
    Campos JF; Resende GG; Barbosa AJA; de Carvalho SC; Lage JA; Cunha PFS; de Souza SCS; Ferrari MLA
    Int J Rheum Dis; 2022 Sep; 25(9):1078-1086. PubMed ID: 35855677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability.
    Juricic G; Brencic T; Tesija-Kuna A; Njegovan M; Honovic L
    Biochem Med (Zagreb); 2019 Feb; 29(1):010707. PubMed ID: 30799976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological variation of serum canine calprotectin concentrations as measured by ELISA in healthy dogs.
    Heilmann RM; Ruaux CG; Grützner N; Cranford SM; Bridges CS; Steiner JM
    Vet J; 2019 May; 247():61-64. PubMed ID: 30971353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
    Heilmann RM; Berghoff N; Mansell J; Grützner N; Parnell NK; Gurtner C; Suchodolski JS; Steiner JM
    J Vet Intern Med; 2018 Mar; 32(2):679-692. PubMed ID: 29460444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A; D'Incà R; Scapellato ML; De Bastiani R; Caccaro R; Mescoli C; Moz S; Bozzato D; Zambon CF; Lorenzon G; Rugge M; Plebani M; Basso D
    Clin Chem Lab Med; 2018 Oct; 56(11):1926-1935. PubMed ID: 29729144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
    Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 19. The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.
    Hiraoka S; Takashima S; Inokuchi T; Nakarai A; Takahara M; Harada K; Seki Y; Watanabe K; Kato J; Okada H
    Intest Res; 2019 Apr; 17(2):202-209. PubMed ID: 30541228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S
    Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.